b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30868916</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>02</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>01</Month>\n            <Day>02</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1477-0903</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>38</Volume>\n                    <Issue>6</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>Jun</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Human &amp; experimental toxicology</Title>\n                <ISOAbbreviation>Hum Exp Toxicol</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>A\xce\xb21-42 increases the expression of neural KATP subunits Kir6.2/SUR1 via the NF-\xce\xbaB, p38 MAPK and PKC signal pathways in rat primary cholinergic neurons.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>665-674</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1177/0960327119833742</ELocationID>\n            <Abstract>\n                <AbstractText>ATP-sensitive potassium channels (KATP) may mediate a potential neuroprotective role in Alzheimer\'s disease (AD). Given that exposure to A\xce\xb21-42 in cultured primary cholinergic neurons for 72 h significantly upregulates the expression of KATP subunits Kir6.2/SUR1, we aim to study the underlying signal transduction mechanisms that are involved in A\xce\xb2<sub>1-42</sub>-induced upregulation of KATP subunits Kir6.2/SUR1. In the present study, we first identified the primary cultured rat cortical and hippocampal neurons using immunocytochemistry. 0.5 \xce\xbcM NF-\xce\xbaB inhibitor SN-50, 2 \xce\xbcM p38MAPK inhibitor SB203580 or 2 \xce\xbcM PKC inhibitor Chelerythrine chloride (CTC) were then added in three separate groups, followed by 2 \xce\xbcM A\xce\xb2<sub>1-42</sub> 30 min later in all 3 groups. Western Blot was performed 72 h later to detect the expression of KATP subunits Kir6.2/SUR1. We found that A\xce\xb2<sub>1-42</sub> significantly increased the level of KATP subunits Kir6.2/SUR1 expression at 72 h when compared with the control group ( p &lt; 0.05). However, when compared with the A\xce\xb2<sub>1-42</sub> group, the level of KATP subunits Kir6.2/SUR1 expression at 72 h significantly decreased in the SN50 + A\xce\xb2<sub>1-42</sub> group, SB203580 + A\xce\xb2<sub>1-42</sub> group, and the CTC + A\xce\xb2<sub>1-42</sub> group ( p &lt; 0.05). Our findings suggest that the NF-\xce\xbaB, p38 MAPK, and PKC signal pathways are partially involved in the upregulation of KATP subunits Kir6.2/SUR1 expression induced by A\xce\xb2<sub>1-42</sub> cytotoxicity in neurons, which supports a potential theoretical basis of targeting these signal pathways in the treatment of AD.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Li</LastName>\n                    <ForeName>Y</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>1 Department of Neurology, Provincial Hospital affiliated to Shandong University, Jinan, Shandong, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ba</LastName>\n                    <ForeName>M</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>2 Department of Neurology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai City, Shandong, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Du</LastName>\n                    <ForeName>Y</ForeName>\n                    <Initials>Y</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>1 Department of Neurology, Provincial Hospital affiliated to Shandong University, Jinan, Shandong, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Xia</LastName>\n                    <ForeName>C</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>1 Department of Neurology, Provincial Hospital affiliated to Shandong University, Jinan, Shandong, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Tan</LastName>\n                    <ForeName>S</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>1 Department of Neurology, Provincial Hospital affiliated to Shandong University, Jinan, Shandong, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ng</LastName>\n                    <ForeName>K P</ForeName>\n                    <Initials>KP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>3 Department of Neurology, National Neuroscience Institute, Singapore, Singapore.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Ma</LastName>\n                    <ForeName>G</ForeName>\n                    <Initials>G</Initials>\n                    <Identifier Source="ORCID">https://orcid.org/0000-0001-7446-5634</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>4 Department of Neurology, Shandong Provincial Qianfoshan Hospital, Shandong University, Jinan, Shandong, People\'s Republic of China.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>03</Month>\n                <Day>14</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>England</Country>\n            <MedlineTA>Hum Exp Toxicol</MedlineTA>\n            <NlmUniqueID>9004560</NlmUniqueID>\n            <ISSNLinking>0960-3271</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C577509">Abcc8 protein, rat</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D016229">Amyloid beta-Peptides</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C489474">Kir6.2 channel</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D016328">NF-kappa B</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D010446">Peptide Fragments</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D024661">Potassium Channels, Inwardly Rectifying</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D064233">Sulfonylurea Receptors</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C075222">amyloid beta-protein (1-42)</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.11.13</RegistryNumber>\n                <NameOfSubstance UI="D011493">Protein Kinase C</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 2.7.11.24</RegistryNumber>\n                <NameOfSubstance UI="D048051">p38 Mitogen-Activated Protein Kinases</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D016229" MajorTopicYN="N">Amyloid beta-Peptides</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002478" MajorTopicYN="N">Cells, Cultured</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D059329" MajorTopicYN="N">Cholinergic Neurons</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016328" MajorTopicYN="N">NF-kappa B</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010446" MajorTopicYN="N">Peptide Fragments</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D024661" MajorTopicYN="N">Potassium Channels, Inwardly Rectifying</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011493" MajorTopicYN="N">Protein Kinase C</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017208" MajorTopicYN="N">Rats, Wistar</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D064233" MajorTopicYN="N">Sulfonylurea Receptors</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D048051" MajorTopicYN="N">p38 Mitogen-Activated Protein Kinases</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">A\xce\xb2</Keyword>\n            <Keyword MajorTopicYN="N">Kir6.2/SUR1</Keyword>\n            <Keyword MajorTopicYN="N">NF-\xce\xbaB</Keyword>\n            <Keyword MajorTopicYN="N">PKC</Keyword>\n            <Keyword MajorTopicYN="N">p38 MAPK</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>1</Month>\n                <Day>3</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>3</Month>\n                <Day>15</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30868916</ArticleId>\n            <ArticleId IdType="doi">10.1177/0960327119833742</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'